Category Specific RSS

Samantha Freidin

Noxopharm receives FDA designation for chemotherapy piggyback drug

Noxopharm (ASX: NOX) will hopefully see an increase in value of their flagship drug following this morning’s announcement. The Company has…

4 years ago

Can fish oil make your baby smarter? Clover Corp trials could hold the answer

Babies born before 37 weeks of pregnancy are considered premature, and often are at risk of getting sick or suffering…

4 years ago

4DMedical to compete with fairy bread for best Aussie invention

Australians are a smart bunch. Although the pavlova is disputed, we gladly claim awesome inventions like the black box flight…

4 years ago

International expansion as more hospitals register for Pharmaxis’ cancer treatment trials

Clinical stage pharmaceutical company Pharmaxis (PXS: ASX) is full steam ahead with their Phase 2 clinical trial for flagship drug,…

4 years ago

Apps, not apples: NZ health food and smoothie bar seeks Plexure to develop new software and app

Popular New Zealand based juice and smoothie bar, TANK is looking to enhance the digital experience for their customers. Understanding…

4 years ago

Digital payments is taking a new direction accelerated by eCommerce

Remember the days of credit card signatures? Yeah, neither did I until I came across a 2014 (!) article whilst…

4 years ago